Editorial: News in Graves' orbitopathy: patients management and treatments. [PDF]
Lanzolla G, Sabini E.
europepmc +1 more source
Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W+7 more
europepmc +1 more source
Association between lipid profiles and Graves orbitopathy: A systematic review and meta analysis
Introduction: Graves orbitopathy (GO) is an autoimmune disorder affecting the tissues around the eyes, seen in 25–50 % of individuals with Graves disease (GD).
Nanny Natalia Mulyani Soetedjo+5 more
doaj
Role of genetics and epigenetics in Graves' orbitopathy. [PDF]
Marinò M+8 more
europepmc +1 more source
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy [PDF]
Jonathan C. P. Roos, Rachna Murthy
openalex +1 more source
Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]
Jian H, Ma RX, He WM.
europepmc +1 more source
Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]
Abounoori M+5 more
europepmc +1 more source
Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]
Alfutaisi A+6 more
europepmc +1 more source
Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy. [PDF]
Sawicka-Gutaj N+6 more
europepmc +1 more source